Immix Biopharma, Inc. (IMMX) has a market capitalization of $521.7M and trades at $9.85. The 52-week range is 1.34-11.61.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11.1, Earnings Per Share (EPS) of $-0.89.
The stock has a beta of 0.21, operates in the Healthcare sector.
